Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom

A. Sarah Walker*, Karina Doris Vihta, Owen Gethings, Emma Pritchard, Joel Jones, Thomas House, Iain Bell, John I. Bell, John N. Newton, Jeremy Farrar, Ian Diamond, Ruth Studley, Emma Rourke, Jodie Hay, Susan Hopkins, Derrick Crook, Tim Peto, Philippa C. Matthews, David W. Eyre, Nicole StoesserKoen B. Pouwels

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

36 Citations (Scopus)
Original languageEnglish
Pages (from-to)2582-2585
Number of pages4
JournalNew England Journal of Medicine
Volume385
Issue number27
DOIs
Publication statusPublished - 30 Dec 2021

Bibliographical note

Funding Information:
Unit. Dr. Matthews is supported by an intermediate fellowship (110110/Z/15/Z) from Wellcome, and Dr. Eyre is supported by a Robertson Fellowship; both authors are funded by senior fellowship awards from the NIHR Oxford Biomedical Research Centre. Dr. Walker is an NIHR Senior Investigator.

Funding Information:
Supported by the Department of Health and Social Care with in-kind support from the Welsh Government, from the Department of Health on behalf of the Northern Ireland Government, and from the Scottish Government; by a grant (NIHR200915) from the Health Protection Research Unit of the National Institute for Health Research (NIHR) in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with the UK Health Security Agency; by the NIHR Oxford Biomedical Research Centre; by the Huo Family Foundation; and by a grant (MC_UU_12023/22) from the Medical Research Council (MRC) UK to the MRC Clinical Trials

Cite this